Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00168194 |
Recruitment Status
:
Completed
First Posted
: September 15, 2005
Last Update Posted
: January 20, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
It remains unclear why some individuals are able to clear HBV from their bodies while in others HBV is a persistent infection. We plan to investigate this process by collecting blood and analysing how the patient's white blood cells respond to different pieces of the HBV virus. We will use new tools that can precisely tell us which component of the immune response may be different in individuals who are chronically infected with HBV and also in individuals who are also infected with HIV.
The primary aims are therefore:
- To characterize HBV-specific T cell responses in HBV chronic carriers, and identify novel immunogenic regions in both HLA-A2+ and non-HLA-A2+ individuals.
- To determine the effect of HIV infection on HBV-specific T-cell responses
Condition or disease |
---|
Hepatitis B HIV Infections |
Study Type : | Observational |
Actual Enrollment : | 104 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History |
Study Start Date : | December 2004 |
Actual Study Completion Date : | December 2009 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
There are two groups of patients in this study. Group A mono-infected with Hepatitis B, and those with co-infection HBV/HIV.
Group A inclusion criteria: (also split into 6 recruiting groups)
- Acute hepatitis B
- Chronic hepatitis B, HBV DNA+ve , normal ALT , HBeAg +ve
- Chronic hepatitis B, HBV DNA +ve , normal ALT, HBeAg -ve
- Chronic hepatitis , HBV DNA +ve, increased ALT, no HBV treatment B, HBeAg +ve
- Chronic hepatitis B, HBV DNA +ve , increased ALT, no HBV treatment B, HBeAg -ve
- Chronic hepatitis B, undergoing 'flare' of hepatitis
Group B inclusion criteria:
- To be HIV/HBV co-infected
All patients:
- To be over 18 years
Exclusion Criteria:
- Those who do not fit the inclusion criteria.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00168194
Australia, Victoria | |
The Alfred Hospital, Commercial Road | |
Melbourne, Victoria, Australia, 3004 |
Principal Investigator: | Sharon Lewin, Professor | Burnet Institute, Melbourne |
Responsible Party: | Jennifer Hoy, Professor Jennifer Hoy, The Alfred |
ClinicalTrials.gov Identifier: | NCT00168194 History of Changes |
Other Study ID Numbers: |
235/04 |
First Posted: | September 15, 2005 Key Record Dates |
Last Update Posted: | January 20, 2012 |
Last Verified: | January 2012 |
Keywords provided by Jennifer Hoy, The Alfred:
HIV |
Additional relevant MeSH terms:
Hepatitis Hepatitis A HIV Infections Hepatitis B Liver Diseases Digestive System Diseases Hepatitis, Viral, Human Virus Diseases Enterovirus Infections Picornaviridae Infections |
RNA Virus Infections Lentivirus Infections Retroviridae Infections Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Hepadnaviridae Infections DNA Virus Infections |